Expression Patterns of Cyclins D1, E and Cyclin-Dependent Kinase Inhibitors p21(Waf1/Cip1) and p27(Kip1) in Urothelial Carcinoma: Correlation with Other Cell-Cycle-Related Proteins (Rb, p53, Ki-67 and PCNA) and Clinicopathological Features

By  

Urologia Internationalis, Vol. 73, Iss. 1, 2008-06 ,pp. : 65-73

Karger

Access to resources Recommend Favorite

Epigenetic Silencing of MicroRNA miR-107 Regulates Cyclin-Dependent Kinase 6 Expression in Pancreatic Cancer

By  

Pancreatology, Vol. 9, Iss. 3, 2009-04 ,pp. : 293-301

Karger

Access to resources Recommend Favorite

Phase 2 trial of the cyclin‐dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein‐expressing germ cell tumors

By  

CANCER, Vol. 121, Iss. 9, 2015-05 ,pp. : 1463-1468

John Wiley & Sons Inc

Access to resources Recommend Favorite

TPX2 as a novel prognostic biomarker for hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 8, 2015-08 ,pp. : 906-918

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitor p18INK4c is involved in protective roles of heme oxygenase-1 in cisplatin-induced acute kidney injury

By            

International Journal of Molecular Medicine, Vol. 34, Iss. 3, 2014-01 ,pp. : 911-917

Spandidos Publications

Access to resources Recommend Favorite